Immuto Scientific
Wednesday, June 05, 2024
Company Presentation
![Platform for Therapeutics](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/icons/seminars/blank.png)
Company Presentation Theater 4
Immuto Scientific is a platform biotech company pioneering a new era in therapeutic discovery by targeting the once thought 'undruggable' proteins and pathways, bringing hope to millions of patients facing conditions with no cure. Our innovative platform combines cutting-edge technology with deep scientific expertise to unlock novel therapies that traditional methods couldn't reach. The heart of our approach is a powerful structure-based drug discovery engine that enables high throughput characterization of protein structures in live cells to identify novel drug targets that are highly disease-specific protein conformations. With our leading-edge platforms, we develop best-in-class therapeutics with exceptional safety and efficacy profiles. We have a preclinical internal pipeline of oncology assets and we partner with companies in multiple different disease areas.
![Immuto Scientific](https://www.abstractscorecard.com/uploads/Tasks/upload/21754/XDQDGWMO-1810340-1-JPG.png)
Company Website:
http://www.immutotherapeutics.com
Lead Product in Development:
ADC for AML
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Company HQ City
Madison
Company HQ State
WI
Company HQ Country
United States
CEO/Top Company Official
Faraz Choudhury, PhD
Development Phase of Primary Product
Pre-Clinical
Primary Speaker